These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35522392)

  • 1. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clincopathological analysis of olfactory neuroblastoma.
    Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
    Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.
    Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ
    Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
    Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B
    Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.
    Cracolici V; Wang EW; Gardner PA; Snyderman C; Gargano SM; Chiosea S; Singhi AD; Seethala RR
    Head Neck Pathol; 2021 Dec; 15(4):1185-1191. PubMed ID: 33929681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma.
    Shah K; Perez-Ordóñez B
    Head Neck Pathol; 2016 Mar; 10(1):85-94. PubMed ID: 26830400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix.
    Inzani F; Angelico G; Santoro A; Travaglino A; Insabato L; Raffone A; Arciuolo D; Scaglione G; D'Alessandris N; Valente M; Carlino A; Rindi G; Zannoni GF
    Virchows Arch; 2022 Apr; 480(4):873-877. PubMed ID: 35091815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
    Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
    Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma.
    Skalova A; Sar A; Laco J; Metelkova A; Miesbauerova M; Steiner P; Švajdler M; Michal M
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):140-146. PubMed ID: 27258560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.
    Czapiewski P; Kunc M; Gorczyński A; Haybaeck J; Okoń K; Reszec J; Lewczuk A; Dzierzanowski J; Karczewska J; Biernat W; Turri-Zanoni M; Castelnuovo P; Taverna C; Franchi A; La Rosa S; Sessa F; Klöppel G
    Hum Pathol; 2018 Sep; 79():144-150. PubMed ID: 29807052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the 2023 North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Navigating New Developments in High Grade Sinonasal Neuroendocrine and Neuroectodermal Neoplasms.
    Rooper LM
    Head Neck Pathol; 2023 Jun; 17(2):299-312. PubMed ID: 37184733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine neoplasms of the sinonasal region.
    Bell D; Hanna EY; Weber RS; DeMonte F; Triantafyllou A; Lewis JS; Cardesa A; Slootweg PJ; Stenman G; Gnepp DR; Devaney KO; Rodrigo JP; Rinaldo A; Wenig BM; Westra WH; Bishop JA; Hellquist H; Hunt JL; Kusafuka K; Perez-Ordoñez B; Williams MD; Takes RP; Ferlito A
    Head Neck; 2016 Apr; 38 Suppl 1():E2259-66. PubMed ID: 26041714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.
    Czapiewski P; Gorczyński A; Haybaeck J; Okoń K; Reszeć J; Skrzypczak W; Dzierżanowski J; Kunc M; Karczewska J; Biernat W
    Pol J Pathol; 2016 Jun; 67(2):130-5. PubMed ID: 27543867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the cytological features of olfactory neuroblastoma: A retrospective single-center study.
    Okano K; Ishida M; Sandoh K; Ito H; Fujisawa T; Iwai H; Tsuta K
    Diagn Cytopathol; 2021 Aug; 49(8):E301-E306. PubMed ID: 33629822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall.
    Inoue H; Matsushima J; Kobayashi S; Sairenchi T; Hirata H; Chida M; Ota S; Ban S; Matsumura Y
    Int J Surg Pathol; 2022 Apr; 30(2):151-159. PubMed ID: 34913369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of NeuroD and GAP43 as diagnostic markers for olfactory neuroblastoma.
    Furukawa T; Tatehara S; Teshima M; Shinomiya H; Inokuchi G; Komatsu M; Hara S; Zen Y; Nibu KI
    Auris Nasus Larynx; 2023 Jun; 50(3):358-364. PubMed ID: 35999123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytopathologic features of olfactory neuroblastoma.
    Mahooti S; Wakely PE
    Cancer; 2006 Apr; 108(2):86-92. PubMed ID: 16456848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.